Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Archer’s 12CQ qubit processor development at the forefront of advanced semiconductors in Australia
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Archer’s 12CQ qubit processor development at the forefront of advanced semiconductors in Australia
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Archer’s 12CQ qubit processor development at the forefront of advanced semiconductors in Australia
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Archer’s 12CQ qubit processor development at the forefront of advanced semiconductors in Australia
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Archer’s 12CQ qubit processor development at the forefront of advanced semiconductors in Australia
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • EMVision’s vision: Point-of-care diagnostic imaging for neurological conditions
    • News

    EMVision’s vision: Point-of-care diagnostic imaging for neurological conditions

    Time is of the essence when a stroke occurs. Each minute that a stroke patient goes without treatment, 1.9 million brain cells die. Early intervention is key and medtech company EMVision Medical Devices (ASX: EMV) wants to help get stroke treatment underway faster. Their point-of-care brain imaging platform allows for rapid diagnosis of neurological conditions

    Read More
    Public
  • Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era
    • News

    Pet-loving tree changers spur a new growth sector for listed vet chain Apiam as demand soars in the pandemic era

    The coronavirus may have inflicted global misery but it’s proven a boon for Apiam Animal Health (ASX: AHX), the only remaining listed veterinary play on the ASX after its nearest peers were taken over by private interests. As well as spurring panic pet purchasing, the pandemic spurred thousands of Australians to relocate to rural and

    Read More
    Public
  • Accounting tech upgrades see Reckon boost customers by 22% as profits flow
    • News

    Accounting tech upgrades see Reckon boost customers by 22% as profits flow

    As the low cost alternative to accounting operation, more businesses are switching their bookkeeping software over to cloud-based Reckon (ASX: RKN) following its transition to cloud-based software, boosting its clientele by 22%. The investment in their tech stack continues to grow the business to now boast more than 106,000 small business customers with a variety

    Read More
    Public
  • Local reporting beating expectations
    • News

    Local reporting beating expectations

    Overnight the S&P500 and Dow closed slightly lower, The Nasdaq closed slightly higher. The energy sector was down after Crude continued to pull back. Otherwise, it was a quiet session. Investors are waiting for more news around Biden’s infrastructure and US CPI Thursday morning. U.S. senators reconvened Sunday to work toward the passage of a

    Read More
    Public
  • New jurisdictions beckon for Novatti and their global expansion plans
    • News

    New jurisdictions beckon for Novatti and their global expansion plans

    Fresh off their 9th consecutive quarter of record processing revenue, digital payments company Novatti Group (ASX: NOV) has their sights on new markets via international expansion where the fintech company has applied for operating licences in new jurisdictions.  It follows a hugely successful fintech model of acquiring regulatory licences and monetising them by leveraging their

    Read More
    Public
  • Nutritional Growth Solutions reaching new heights with market expansion into China
    • News

    Nutritional Growth Solutions reaching new heights with market expansion into China

    Nutritional Growth Solutions (ASX: NGS) is reaching new heights on their growth chart with expansion into global markets, confirming the launch of their proprietary Healthy Height® shake range in Chemist Warehouse in China. Addressing an overlooked subset of the nutritional supplement market, NGS creates clinically proven supplements to support healthy growth and development in children

    Read More
    Public
  • Cars returning to the road as Smart Parking boosts portfolio with acquisition of 68 new sites
    • News

    Cars returning to the road as Smart Parking boosts portfolio with acquisition of 68 new sites

    As smart city technology continues to be adopted world wide, parking specialists Smart Parking (ASX: SPZ) have boosted their European portfolio with the acquisition of Enterprise Parking Solutions which includes their 68 sites under management for a minimal fee.  The addition of EPS and their managed parking sites for $1.54 million increases Smart Parking’s total

    Read More
    Public
  • Annual demand for gloves to reach $57.1b as VIP Gloves’ production surges
    • News

    Annual demand for gloves to reach $57.1b as VIP Gloves’ production surges

    VIP Gloves (ASX: VIP) is on target to continue its recent growth having reopened its Malaysian manufacturing facility, powering its supply to fulfil forecast growth in the global nitrile glove market. After a brief downtime while the company updated operational activities to comply with Malaysian Government Covid-19 requirements, VIP, which recently announced a 164% Year-on-Year

    Read More
    Public
  • US markets showing signs of breaking higher
    • News

    US markets showing signs of breaking higher

    Overnight the SP500 and Nasdaq closed in the all-time high territory. The Dow is still testing resistance. Technically we are seeing signs of continuation on both the Nasdaq and SP500 charts. Tonight, we will see further Jobs data. There are a few large names to report tonight and next week, but most of the US

    Read More
    Public
  • MDMA usage at University is through the roof as Emyria takes aim at mental health
    • News

    MDMA usage at University is through the roof as Emyria takes aim at mental health

    Harbouring more MDMA than music festival goers, the University of Western Australia (UWA) is leading the way in research around the use of MDMA as a psychedelic medication. Clinical drug development and care delivery company Emyria (ASX: EMD) has today announced a partnership with UWA, confirming access to their library of MDMA- like compounds developed

    Read More
    Public
  • «
  • ‹
  • 228
  • 229
  • 230
  • 231
  • 232
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.